Surmodics Inc (SRDX, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on September 30, 2021.
For the last quarter Surmodics Inc reported a revenue of $24.0 million, compared with the revenue of $22.54 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $105.1 million, an increase of 10.8% from last year. For the complete 30-year financial data, please go here.. For the last five years Surmodics Inc had an average revenue growth rate of 8.7% a year.
The reported diluted earnings per share was 30 cents for the year, an increase of 275% from previous year. The Surmodics Inc had an operating margin of 7.37%, compared with the operating margin of -1.32% a year before. The 10-year historical median operating margin of Surmodics Inc is 30.51%. The profitability rank of the company is 7 (out of 10).
At the end of the fiscal year, Surmodics Inc has the cash and cash equivalents of $31.2 million, compared with $30.8 million in the previous year. The company had no long term debt. Surmodics Inc has a financial strength rank of 8 (out of 10).
At the current stock price of $47.55, Surmodics Inc is traded at 12.6% premium to its historical median P/S valuation band of $42.24. The P/S ratio of the stock is 6.25, while the historical median P/S ratio is 5.56. The stock gained 25.26% during the past 12 months.
For the complete 20-year historical financial data of SRDX, click here.
